Skip to content

Clinical trials

Respiratory Tract Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: Belgium Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20144
20152
20162
20173
20182
20194
20202
20211
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting6
Terminated3
Enrolling by invitation1
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Pfizer3
Eli Lilly and Company2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
United Therapeutics2
Bellus Health Inc. - a GSK company1
Daiichi Sankyo1
Drahomir Aujesky1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases27
Lung Diseases21
Lung Neoplasms6
Neoplasms6
Respiratory Tract Neoplasms6
Thoracic Neoplasms6
Asthma5
Carcinoma, Non-Small-Cell Lung5
Lung Diseases, Obstructive5
Neoplasms by Site5

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.